Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Technique
3.2. Market Snippet by Application
3.3. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increase in demand for disease-modifying and targeted treatments
4.1.1.2. The high incidence rate of angina pectoris
4.1.1.3. Improved spending on healthcare
4.1.1.4. The rise in the availability of effective treatment methods
4.1.1.5. Technological Advancements towards Personalized Cardiovascular Medicines
4.1.2. Restraints:
4.1.2.1. Growing Use of Minimally Invasive Surgeries
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Value Chain Analysis
5.4. PEST Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
5.9. Patent Trends
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Technique
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique Segment
7.3. Market Attractiveness Index, By Technique Segment
7.3.1. High-dose Rate (HDR) Brachytherapy*
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.2. Low-dose Rate (LDR) Brachytherapy
8. By Application
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
8.3. Market Attractiveness Index, By Application Segment
8.3.1. Prostate Cancer*
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3.2. Gynecological Cancer
8.3.3. Breast Cancer
8.3.4. Others
9. By Region
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.3. Market Attractiveness Index, By Region
9.4. North America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. The U.S.
9.4.5.2. Canada
9.4.5.3. Mexico
9.5. Europe
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. Germany
9.5.5.2. The U.K.
9.5.5.3. France
9.5.5.4. Italy
9.5.5.5. Spain
9.5.5.6. Rest of Europe
9.6. South America
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.6.5.1. Brazil
9.6.5.2. Argentina
9.6.5.3. Rest of South America
9.7. Asia Pacific
9.7.1. Introduction
9.7.2. Key Region-Specific Dynamics
9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.7.5.1. China
9.7.5.2. India
9.7.5.3. Japan
9.7.5.4. Australia
9.7.5.5. Rest of Asia Pacific
9.8. The Middle East and Africa
9.8.1. Introduction
9.8.2. Key Region-Specific Dynamics
9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Elekta*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Eckert & Zieglar BEBIG
11.3. Varian Medical Systems, Inc.
11.4. Panacea Medical Technologies
11.5. Theragenics Corporation
11.6. Oncura (GE Healthcare)
11.7. IsoAid
11.8. TeamBest
11.9. Other Companies (*LIST NOT EXHAUSTIVE)
12. DataM Intelligence
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us